Skip to content

Clinical trials

Phase 2 Lupus Erythematosus, Systemic trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Phase: Phase 2 Country / region: Germany Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20101
20112
20132
20142
20153
20161
20175
20182
20193
20204
20212
20221
20232
20242
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Active, not recruiting6
Terminated6
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb3
Novartis Pharmaceuticals3
AbbVie2
Amgen2
Charite University, Berlin, Germany2
EMD Serono2
GlaxoSmithKline2
Janssen Research & Development, LLC2
Pfizer2
Ablynx, a Sanofi company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic37
Arthritis, Rheumatoid3
Autoimmune Diseases3
Connective Tissue Diseases3
Lupus Nephritis3
Immune System Diseases2
Myasthenia Gravis1
Proteinuria1

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.